STAAR Surgical Q1 Revenue Jumps 119% YoY

STAAR Surgical posted Q1 revenue of $93.5 million, up 119.6% YoY and beating the $78.74 million estimate.
Adjusted EPS rose to $0.10 versus consensus $0.05, while adjusted EBITDA turned positive $24.4 million ($0.48 per share).
China sales rebounded to $47.4 million and U.S. sales exceeded $6 million, up 22% YoY, driving share price 16% higher.
Gross margin improved to 73.6% from 65.8% and net income turned positive $5.2 million versus a $54.2 million loss a year ago.